Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
Pfizer Inc. (PFE) Presents at Jefferies Global Healthcare Conference 2026 Transcript
05:02pm, Wednesday, 03'rd Jun 2026
Pfizer Inc. (PFE) Presents at Jefferies Global Healthcare Conference 2026 Transcript
3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now
03:00pm, Wednesday, 03'rd Jun 2026
PepsiCo, AT&T, and Pfizer are blue chip dividend stocks that offer high yields. Their valuations are incredibly modest when compared to the average S&P 500 stock.
Pfizer vs Merck: Chasing High Yield vs Higher Returns
10:06am, Wednesday, 03'rd Jun 2026
Pfizer (NYSE:PFE | PFE Price Prediction) and Merck (NYSE:MRK) both just closed earnings chapters that frame the 2026 dividend debate clearly.
Bristol Myers vs. Pfizer: Which High‑Yield Dividend Stock Wins Now?
03:45am, Wednesday, 03'rd Jun 2026
Both are working hard to get around patent cliffs. One of them seems to have made more progress on that front.
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026
02:45am, Wednesday, 03'rd Jun 2026
This biotech is making solid progress with several pipeline candidates. It could have a stronger lineup of approved products within a few years.
How to Recession-Proof Your Retirement Before the Second Half of 2026
01:39pm, Tuesday, 02'nd Jun 2026
You should consider these strategies if you can't afford to wait out another market crash.
Pfizer's Obesity and Oncology Pipeline Sets Up a Catalyst-Rich 2026
10:11am, Tuesday, 02'nd Jun 2026
PFE targets a catalyst-rich 2026 with pivotal obesity and oncology studies, key data readouts, and regulatory decisions across its pipeline.
Why Pfizer's Current Price May Be Too Cheap to Ignore
10:03am, Tuesday, 02'nd Jun 2026
Pfizer (NYSE:PFE | PFE Price Prediction) is one of those names where the headline narrative (COVID hangover, patent cliff) keeps overshadowing what is actually a defensive cash machine trading at a si
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
10:01am, Tuesday, 02'nd Jun 2026
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
3 Dividend Stocks to Buy and Hold Forever
03:00am, Tuesday, 02'nd Jun 2026
These aren't the most exciting businesses, but they have a lot to offer to long-term investors.
Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks
11:15pm, Monday, 01'st Jun 2026
Bristol Myers Squibb has an attractive 4.4% yield, and its 16x P/E is below the pharma average of 24x.
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
02:19pm, Monday, 01'st Jun 2026
AbbVie and Pfizer chart distinct paths in revenue growth, risk, and valuation. Explore how their financials and strategies stack up for investors this year.
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
10:00am, Monday, 01'st Jun 2026
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Gold
Is Pfizer the Perfect Stock to Own with Kevin Warsh Heading the Fed?
04:44am, Monday, 01'st Jun 2026
Pfizer could attract investors if Warsh's "regime change" at the Fed leads to market turbulence.
Is Pfizer Stock a "Value Trap" or a Generational Opportunity?
11:15am, Sunday, 31'st May 2026
Pfizer's stock has fallen more than 50% from its 2021 high. The stock is trading below its pre-coronavirus pandemic level.
